Literature DB >> 7890233

Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans.

M Ledeboer1, A A Masclee, M R Batstra, J B Jansen, C B Lamers.   

Abstract

The effect of cholecystokinin (CCK) on the lower oesophageal sphincter (LOS) pressure, frequency of transient LOS relaxations, and the number of reflux episodes was investigated in six healthy subjects. LOS pressure was recorded on four separate occasions during continuous intravenous infusion of either saline or CCK-33 in doses of 0.25, 0.5, or 1.0 Ivy Dog units per kg body weight per hour (IDU.kg-1.h-1) for 90 minutes. Plasma CCK concentrations did not change during saline infusion, but increased significantly from 2.5 (0.3) pmol/l to steady state levels of 4.0 (0.4) pmol/l, 6.1 (0.4) pmol/l, and 9.3 (0.9) pmol/l respectively starting from 30 minutes. LOS pressure did not change significantly during infusion of saline or of CCK-33 at doses of 0.25 or 0.5 IDU.kg-1.h-1. However, a significant (p < 0.05) reduction in LOS pressure to a minimum level of 12 (4) mm Hg at 30 minutes compared with basal level (18 (4) mm Hg) and compared with saline was observed during infusion of CCK-33 at a dose of 1.0 IDU.kg-1.h-1. In addition, oesophageal motility and pH were recorded simultaneously in these six subjects on two separate occasions one hour before (fasting) and three hours during administration of a gastric load (dextrose 5%, pH 3) combined with continuous intravenous infusion of saline or CCK-33 at a dose of 1.0 IDU,kg-1.h-1. Plasma CCK concentrations did not change during the gastric load combined with saline, but increased significantly to a steady state level of 10.8 (0.8) pmol/l during intravenous infusion of CCK. The number of transient LOS relaxations increased significantly in the first hour during administration of the gastric load compared with fasting levels, both during saline infusion (fasting: 1.7 (0.6)/h, 1st hour: 4.3 (1.2)/h) and during CCK infusion (fasting: 1.7 (0.5)/h, 1st hour: 3.8 (0.7)/h). In the second and third hours the number of transient LOS relaxations fell to fasting levels in both experiments. No significant differences were observed in the number and type of transient LOS relaxations, mechanism of gastro-oesophageal reflux, or duration of acid exposure between the two experiments. It is concluded that in healthy subjects infusion of CCK-33 in a dose of 1.0 IDU.kg-1.h-1 significantly reduces LOS pressure but does not affect the frequency of transient LOS relaxations or acid exposure time during a continuous liquid gastric load.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890233      PMCID: PMC1382350          DOI: 10.1136/gut.36.1.39

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  A comparison of high and low fat meals on postprandial esophageal acid exposure.

Authors:  D J Becker; J Sinclair; D O Castell; W C Wu
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

2.  Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal.

Authors:  M Fried; E A Mayer; J B Jansen; C B Lamers; I L Taylor; S R Bloom; J H Meyer
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

3.  Characteristics of transient lower esophageal sphincter relaxation in humans.

Authors:  R K Mittal; R W McCallum
Journal:  Am J Physiol       Date:  1987-05

4.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man.

Authors:  W P Hopman; J B Jansen; C B Lamers
Journal:  Scand J Gastroenterol       Date:  1985-09       Impact factor: 2.423

6.  Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux.

Authors:  J Dent; R H Holloway; J Toouli; W J Dodds
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

7.  Molecular forms of cholecystokinin in plasma from normal and gastrectomized human subjects following a fat meal.

Authors:  J B Jansen; C B Lamers
Journal:  Peptides       Date:  1987 Sep-Oct       Impact factor: 3.750

8.  Gastric distention: a mechanism for postprandial gastroesophageal reflux.

Authors:  R H Holloway; M Hongo; K Berger; R W McCallum
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

9.  Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressure.

Authors:  S R Brazer; D S Borislow; R A Liddle
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

10.  Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis.

Authors:  R K Mittal; R W McCallum
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  13 in total

1.  Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.

Authors:  J Boulant; S Mathieu; M D'Amato; A Abergel; M Dapoigny; G Bommelaer
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms.

Authors:  Gregory L Austin; Michelle T Thiny; Eric C Westman; William S Yancy; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2006-07-27       Impact factor: 3.199

3.  Relationship between postprandial esophageal acid exposure and meal volume and fat content.

Authors:  K Iwakiri; M Kobayashi; M Kotoyori; H Yamada; T Sugiura; Y Nakagawa
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

4.  Effect of amino acids on lower esophageal sphincter characteristics and gastroesophageal reflux in humans.

Authors:  H A Gielkens; C B Lamers; A A Masclee
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

5.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

6.  Effect of gastrin-17 on lower esophageal sphincter characteristics in man.

Authors:  J W Straathof; C B Lamers; A A Masclee
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

7.  Cholecystokinin induces esophageal longitudinal muscle contraction and transient lower esophageal sphincter relaxation in healthy humans.

Authors:  Arash Babaei; Ravinder Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-14       Impact factor: 4.052

8.  Evaluation of surgical outcomes and gallbladder characteristics in patients with biliary dyskinesia.

Authors:  M Shirin Sabbaghian; Barrie S Rich; Gary D Rothberger; Jonathan Cohen; Steven Batash; Elissa Kramer; H Leon Pachter; Stuart G Marcus; Peter Shamamian
Journal:  J Gastrointest Surg       Date:  2008-06-10       Impact factor: 3.452

9.  Risk factors of gastroesophageal reflux disease in Shiraz, southern Iran.

Authors:  Mehdi Saberi-Firoozi; Farnaz Khademolhosseini; Maryam Yousefi; Davood Mehrabani; Najaf Zare; Seyed Taghi Heydari
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

Review 10.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.